Full Text View
Tabular View
No Study Results Posted
Related Studies
Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)
This study has been completed.
Study NCT00398749   Information provided by Janssen-Cilag B.V.

First Received on November 10, 2006.   Last Updated on November 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anemia
Neoplasms
More general conditions related to this trial
Hematologic Diseases
Interventions listed in this trial
Epoetin alfa
Additional drug interventions recognized in this trial
Antineoplastic Agents
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Janssen-Cilag B.V.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services